GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $772,000 | -23.2% | 24,167 | -16.7% | 0.71% | -2.5% |
| Q1 2022 | $1,005,000 | +53.0% | 29,001 | +29.1% | 0.73% | +61.4% |
| Q4 2021 | $657,000 | -54.8% | 22,461 | -14.8% | 0.45% | +5.1% |
| Q3 2020 | $1,454,000 | -26.6% | 26,362 | -15.9% | 0.43% | -34.8% |
| Q2 2020 | $1,980,000 | -21.9% | 31,362 | -36.8% | 0.66% | -37.9% |
| Q1 2020 | $2,536,000 | -33.8% | 49,630 | +3.1% | 1.06% | -20.9% |
| Q4 2019 | $3,828,000 | +61.2% | 48,155 | 0.0% | 1.35% | +48.8% |
| Q3 2019 | $2,374,000 | +10.3% | 48,155 | +20.8% | 0.90% | +14.7% |
| Q2 2019 | $2,152,000 | +4.3% | 39,866 | -22.7% | 0.79% | -13.7% |
| Q1 2019 | $2,064,000 | 0.0% | 51,552 | 0.0% | 0.91% | +3.6% |
| Q4 2018 | $2,064,000 | +4.9% | 51,552 | 0.0% | 0.88% | +30.7% |
| Q3 2018 | $1,967,000 | -14.6% | 51,552 | +6.2% | 0.68% | -20.8% |
| Q2 2018 | $2,303,000 | +61.3% | 48,535 | +64.1% | 0.85% | +45.1% |
| Q1 2018 | $1,428,000 | – | 29,569 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |